Following BLyS description, its role in human autoimmunity was sought; circulating levels of BLyS are elevated in patients with SLE as described by the group of Stohl, and therefore it was targeted therapeutically (25). The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.